Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2018
A Nationwide Survey of Pediatric-onset Japanese Encephalitis in JapanEtsuro Nanishi, Takayuki Hoshina, Masafumi Sanefuji, et al.
Molecular and Clinical Oncology|October 17, 2019
Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literatureHiroki Izumi, Masahiro Kodani, Jun Kurai, et al.
Anticancer Research|February 10, 2017
Frequency of Epidermal Growth Factor Receptor Mutation in Smokers with Lung Cancer Without Pulmonary EmphysemaKenichi Takeda, Akira Yamasaki, Tadashi Igishi, et al.
International Journal of Oncology|February 6, 2015
A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancerTomohiro Sakamoto, Masahiro Kodani, Miyako Takata, et al.
International Journal of Oncology|January 10, 2015
Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studiesHiroki Izumi, Hirokazu Touge, Tadashi Igishi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004)Kakuhiro Yamaguchi, Shun Takao, Nobuhiro Kanaji, et al.
Thoracic Cancer|October 17, 2024
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational studyTakeshi Masuda, Yukari Tsubata, Kojirou Hata, et al.
Respirology (Carlton, Vic.)|June 4, 2026
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective ValidationTetsu Hirakawa, Kakuhiro Yamaguchi, Shun Takao, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Histologic transformation of epidermal growth factor receptor-mutated lung cancerDaichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, et al.
Lancet (London, England)|March 12, 2019
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trialHiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi, et al.
Pageof 3